News

Pregnant people need to be protected through research rather than from research, the authors contend.

As the COVID-19 pandemic persists, SARS-CoV-2 vaccines offer the potential to halt the spread of the virus. Yet, we know very little about the effectiveness and safety of the vaccines during pregnancy.

NIH-funded study suggests mother-to-infant transmission appears to be rare

Read about NICHD’s research findings and activities from 2020.

National Institutes of Health study suggests women with mood disorders, gestatational diabetes may have a higher risk.

Traces of genetic material from the placenta and other organs circulating in a pregnant woman’s blood stream could potentially be used to predict the risk for complications in later pregnancy, according to a new NICHD-supported study.

A mouse study funded by the National Institutes of Health suggests that a step in the in vitro fertilization (IVF) procedure could account for the higher rate of complications in pregnancies resulting from this form of assisted reproductive technology (ART). The researchers linked the culture of embryos in laboratory dishes after fertilization with impaired growth of the placenta, smaller fetal size, and a higher risk of preeclampsia, a serious pregnancy-related blood pressure disorder.

Compared to other women, deaf and hard of hearing women have a higher risk for pregnancy and birth complications such as gestational diabetes and blood pressure disorders, according to a study funded by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development. Moreover, infants of deaf and hard of hearing women were more likely to be born preterm, have low birth weight, and receive a low Apgar score—a screening test used to determine the baby’s need for additional medical services.

Researchers to evaluate medical records of 21,000 pregnant women

Program will include lessons learned from caring for pregnant women with COVID-19.

Gene modifications correspond to blood pressure increases at distinct pregnancy intervals.

To expand the reach of its crowdsourcing pregnancy research project, the National Institutes of Health (NIH) recently launched a Spanish version of PregSource®.

NICHD’s new initiative—Pregnancy for Every Body—educates plus-size pregnant women about healthy pregnancy and the importance of working with a healthcare provider to develop a pregnancy plan.

A new imaging technique to track maternal blood flow to the placenta has the potential to help diagnose several common complications in early pregnancy, according to a study funded by the National Institutes of Health. Researchers used the technique, referred to as pseudo-continuous arterial spin labeling magnetic resonance imaging (pCASL MRI), to identify women with reduced placental blood flow who later developed one or more complications.

Sleeping on the back or side through the 30th week of pregnancy does not appear to increase the risk of stillbirth, reduced size at birth, or high blood pressure disorders of pregnancy, suggests an analysis funded by the NICHD.

Improved data reporting among the factors critical to reducing life-threatening complications of pregnancy and childbirth

Exposure to high levels of certain common air pollutants in early pregnancy may increase the risk of pregnancy-induced high blood pressure, suggests an analysis by researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development. In addition, exposure to a class of air pollutants known as volatile organic compounds in mid-pregnancy may increase the risk for preeclampsia, a potentially fatal disorder of pregnancy affecting blood pressure and kidney function.

Elevated blood pressure in the first trimester of pregnancy, or an increase in blood pressure between the first and second trimesters, raises the chances of a high blood pressure disorder of pregnancy, according to a study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health.

Patient advocates, healthcare providers and researchers help map a future research agenda aimed at reducing maternal mortality and severe morbidity.